retatrutide safety trial results What caught my attention wasn't just the number. It was what the number represents. New Phase 3 data for showed an average weight loss of 28.3% at the highest dose GLP-1 Medications for Weight Loss:

Researchers say people living with diabetes often face a Now, a large national study from Sweden found that certain medications commonly prescribed for diabetes and weight loss specifically GLP-1 receptor agonists like Ozempic and Wegovy may also help reduce the risk of worsening mental illness in people with anxiety or depression

This makes it a valuable tool for those looking to manage their weight, balance blood sugar levels, or improve gut health

Neuropeptides (2018) 71:7080

Findings were assessed across multiple independent datasets, including FinnGen, Psychiatric Genomics Consortium (PGC), and UK Biobank, and were synthesized through meta-analysis